Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? - Wikidata - awgldk - TriplyDB

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

http://www.wikidata.org/entity/Q33442816

about

A review of experimental studies of hydrogen as a new therapeutic agent in emergency and critical care medicine Metabolic syndrome: an important risk factor for Parkinson's disease Acarbose: a new option in the treatment of ulcerative colitis by increasing hydrogen production Managing ulcerative colitis by increasing hydrogen production via oral administration of Acarbose The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas Research Cigarette smoke exposure impairs reverse cholesterol transport which can be minimized by treatment of hydrogen-saturated saline.Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome.Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors Recent advances in hydrogen research as a therapeutic medical gas.Hydrogen resuscitation, a new cytoprotective approach.Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications.Metal-based anti-diabetic drugs: advances and challenges.Molecular hydrogen and radiation protection.Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases.Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus.Discovery of novel inhibitors for human intestinal maltase: virtual screening in a WISDOM environment and in vitro evaluation.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Cinnamon extract inhibits α-glucosidase activity and dampens postprandial glucose excursion in diabetic rats.Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats.Lactulose: an effective preventive and therapeutic option for ischemic stroke by production of hydrogen.Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.Non-gut microbiota as a source of bioactive hydrogen.The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.Physico-Chemical, Biological and Therapeutic Characteristics of Electrolyzed Reduced Alkaline Water (ERAW)Emerging mechanisms and novel applications of hydrogen gas therapy

P2860

Q26829737-FAFF8D19-A30B-4AE9-B995-EC7E310CCA9B Q27023711-7A278DB8-FB9D-4620-89A9-67509C122C6D Q33459385-6B34073C-AFAB-4247-9452-A3244129E94D Q33460199-2A27E8D9-64B6-4CB6-BE73-5C4E7FCFD1E3 Q35596044-DEB7EEC2-89BD-4965-912F-E2AE8C00B6E1 Q36344004-2B8A0897-BBB8-4194-B0FB-0C1D63AC5468 Q36920593-64AD5CB9-D5EE-41DF-A93F-F58B8420ED5A Q37703682-570C65FE-2808-413F-916C-35EB2BD2EA55 Q37785099-56E870A1-8E5E-47C1-A15D-69325DFBFB40 Q37830750-FE84BDE3-D26B-4D7F-8D15-0A05B39F5A1C Q37898719-123072DD-9F49-4768-8B4D-E5D67444C8B0 Q37900507-F118E944-6486-473F-BDA8-44AADD74B382 Q38005799-BA9F157F-37BE-44E1-BEF0-07ECC3F33F25 Q38020483-9C6F5056-8D0F-4D64-98DD-85FCC81AB16A Q38068353-353E7347-A613-420A-8649-0FF0AFDC49D1 Q38333652-684F7065-9AC9-4903-941F-C1F22E80AEFD Q38563239-A7CAED9E-4F04-49A0-B045-7FAA29A6AEAE Q39734720-C0ADE706-96EA-4F23-BCE1-6697FA0059B3 Q39790288-80C580E9-BE1A-4D6B-B6AD-BAF4C1DF8ED6 Q41761034-53532D7E-F869-448D-A6A5-9B2708CE3184 Q41840451-F9588382-3C26-4D5E-A872-C6F02F5F9710 Q47144400-CB6AEAF2-FC00-417B-91D0-4DFAD50A1357 Q48020385-8E0054D2-6E82-46F6-B7A8-48E3ACFF8DF3 Q55114052-6BD6A786-DC49-408E-8C7D-95658F280BBF Q56454304-C125327E-A430-4C01-A9A0-B4866159CAA2 Q57492275-274F0429-5346-448F-9FC7-B8CB3DB8D86A

P2860

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

http://www.wikidata.org/entity/Q33442816

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@ast

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@en

type

label

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@ast

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@en

prefLabel

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@ast

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@en

P1433

Q33442816-7D007E1A-90AB-40D8-BA50-30CF080E974A

P1476

Q33442816-7B3D9C17-3D03-439B-89AF-3EBAD8F4D32E

P2093

Q33442816-6D49E26F-C27C-44E7-AC40-C0EA7FBB35F8

Q33442816-7930F86E-1838-451E-BD62-34BF53F08479

Q33442816-8BA23435-4F59-428A-853B-8BB0E69D0F72

Q33442816-E552DB8D-8501-4D06-9A36-F389D3C157E1

Q33442816-F6128471-2675-427E-A5ED-0FE2BBAEB402

P2860

Q33442816-13B11530-E119-4DDE-9F3B-A10BD2789827

Q33442816-23F16788-61B4-480E-BAC8-29BBCA35E8D8

Q33442816-26CDB331-A381-4761-887E-92CD03167DFB

Q33442816-47E05DCE-8514-4948-9D32-20726B881FC2

Q33442816-58F6536C-9253-4D78-B203-E5FC5BAEBB1D

Q33442816-708A02BD-1FB0-43E0-B810-E6F82C0267E0

Q33442816-76B5C522-90A1-4FE9-8311-AA92CE4D4143

Q33442816-7D6FDEC9-CC62-42A5-A382-E3D247D36F22

Q33442816-9DC09068-537F-43A8-8389-F3AFC501A6A7

Q33442816-A04CA272-A6B0-4B7A-A6D9-41537DC6EB92

P304

Q33442816-571A5533-C2C6-4E0D-ABA1-97DC499300DF

P31

Q33442816-6E95CD1F-6012-4129-8E83-5CD29FB96D3F

P356

Q33442816-523CD847-0911-404B-93D3-5930DFAB9832

P407

Q33442816-ACF0232B-A0A3-4624-AA1A-85C062D1DB58

P433

Q33442816-DFA048B0-B72C-41E2-9DEC-B67A74840D50

P478

Q33442816-C15B7801-4A02-4216-AB81-F7455C9AEBD6

P50

Q33442816-8A3AAB29-2E7C-4161-B333-D97CFB23B73B

P577

Q33442816-1ECFA064-014D-4679-8C72-E518C8F3ACCB

P5875

Q33442816-F29E1E81-8AB7-4B76-8289-C3152C6939E7

P698

Q33442816-B7226978-E0B1-4DE2-BDA0-4431A6A072F1

P921

Q33442816-7484B2CC-19E4-4B59-BF3D-22D50A2CFD1E

P356

J.FEBSLET.2009.05.052

P1433

P1476

Are the effects of alpha-gluco ...... in the gastrointestinal tract?

@en

P2093

Ikuroh Ohsawa

http://www.w3.org/2001/XMLSchema#string

Keiichi Fukuda

http://www.w3.org/2001/XMLSchema#string

Motoaki Sano

http://www.w3.org/2001/XMLSchema#string

Shigeo Ohta

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Production and excretion of hydrogen gas in man.

Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.

Redox regulation of the afferent arteriole and tubuloglomerular feedback.

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

Why have antioxidants failed in clinical trials?

Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

A role for oxidized phospholipids in atherosclerosis.

P304

2157-2159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2009.05.052

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

583

http://www.w3.org/2001/XMLSchema#string

P50

Kentaro Hayashida

P577

2009-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26275190

http://www.w3.org/2001/XMLSchema#string

P698

19505462

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio